Related Experiment Videos

Doxorubicin combination chemotherapy in ovarian carcinoma

B N Bundy, G A Omura

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology

|April 1, 1987

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Dose-escalated cyclophosphamide, doxorubicin, vincristine, prednisone, and etoposide (CHOPE) chemotherapy for patients with diffuse lymphoma: Cancer and Leukemia Group B studies 8852 and 8854.

Cancer·2001

Cyclophosphamide, doxorubicin, vincristine, prednisone, and etoposide (CHOPE) for advanced-stage Hodgkin's disease: CALGB 8856.

Cancer investigation·2001

A phase III, randomized, double-blind, placebo-controlled study of peldesine (BCX-34) cream as topical therapy for cutaneous T-cell lymphoma.

Journal of the American Academy of Dermatology·2001

Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: an intergroup study of the Gynecologic Oncology Group, Southwestern Oncology Group, and Eastern Cooperative Oncology Group.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2001

Inhibitors of the enzyme purine nucleoside phosphorylase as potential therapy for psoriasis.

Current pharmaceutical design·2000

Pharmacokinetics and pharmacodynamics of peldesine (BCX-34), a purine nucleoside phosphorylase inhibitor, following single and multiple oral doses in healthy volunteers.

Journal of clinical pharmacology·2000

See all related articles